SISTERS: Spasticity In Stroke Study - Randomized Study

Completed · Phase 4

Conditions studied: Severe Spasticity

In brief

To demonstrate that Intrathecal Baclofen (ITB) Therapy, compared to Best Medical Treatment (BMT), has superior efficacy in the treatment of severe spasticity in adult post-stroke patients with generalized spastic hypertonia who have not reached their therapy goal with other treatment interventions assessed by a decrease in the average Ashworth Scale (AS) score in the lower extremities.

Key facts

Study ID
NCT01032239
Run by
MedtronicNeuro
People needed
61
Starts
2009-11-01
Expected to finish
2016-09-01
Last updated by the study team
2018-02-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.